Alterations in peripheral blood memory B cells in patients with active rheumatoid arthritis are dependent on the action of tumour necrosis factor
Authors:
- M Margarida Souto-CarneiroMSM Margarida Souto-Carneiro
- Vijayabhanu MahadevanVMVijayabhanu Mahadevan
- Kazuki TakadaKTKazuki Takada
- Ruth Fritsch-StorkRFRuth Fritsch-Stork
- Toshihiro NankiTNToshihiro Nanki
- Margaret BrownMBMargaret Brown
- Thomas A FleisherTFThomas A Fleisher
- Mildred WilsonMWMildred Wilson
- Raphaela Goldbach-ManskyRGRaphaela Goldbach-Mansky
- Peter E LipskyPLPeter E Lipsky
Open Access
- 5 June 2009
- journal article
- research article
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 11 (3) , R84
Abstract
Introduction: Disturbances in peripheral blood memory B cell subpopulations have been observed in various autoimmune diseases, but have not been fully delineated in rheumatoid arthritis (RA). Additionally, the possible role of tumour necrosis factor (TNF) in regulating changes in specific peripheral blood memory B cell subsets in RA is still unclear. Methods: The frequency and distribution of B cell subsets in the peripheral blood and synovial membrane of active RA patients with long-standing disease have been analysed. Additionally, the possible role of TNF in causing disturbances in memory B cell subsets in RA patients was assessed in a clinical trial with the specific TNF-neutralising antibody, infliximab. Results: RA patients, independent of disease duration, have a significantly lower frequency of peripheral blood pre-switch IgD+CD27+ memory B cells than healthy individuals, whereas post-switch IgD-CD27+ accumulate with increased disease duration. Notably, both pre-switch IgD+CD27+ and post-switch IgD-CD27+ memory B cells accumulate in the synovial membrane of RA patients. Finally, anti-TNF therapy increased the frequency of pre-switch IgD+CD27 memory B cells in the peripheral blood. Conclusions: The data suggest that decreases in peripheral blood IgD+CD27+ pre-switch memory B cells in RA reflect their accumulation in the synovial tissue. Moreover, the significant increase in the peripheral blood pre-switch memory B cells in patients who underwent specific TNF-blockade with infliximab indicates that trafficking of memory B cells into inflamed tissue in RA patients is regulated by TNF and can be corrected by neutralising TNF.Keywords
This publication has 63 references indexed in Scilit:
- Clinical significance of synovial lymphoid neogenesis and its reversal after anti-tumour necrosis factor α therapy in rheumatoid arthritisAnnals of the Rheumatic Diseases, 2009
- Inflammation and ectopic lymphoid structures in rheumatoid arthritis synovial tissues dissected by genomics technology: Identification of the interleukin‐7 signaling pathway in tissues with lymphoid neogenesisArthritis & Rheumatism, 2007
- The role of B cells in the pathogenesis of rheumatoid arthritis.2005
- Pathogenesis of rheumatoid arthritis: how early is early?Arthritis Research & Therapy, 2005
- B Lymphocyte Depletion in Rheumatoid Arthritis:Targeting of CD202004
- Functional analysis of human memory B-cell subpopulations: IgD+CD27+ B cells are crucial in secondary immune response by producing high affinity IgMClinical Immunology, 2003
- Ectopic Germinal Center Formation in Rheumatoid SynovitisAnnals of the New York Academy of Sciences, 2003
- Plasma Cell Development in Synovial Germinal Centers in Patients with Rheumatoid and Reactive ArthritisThe Journal of Immunology, 1999
- Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis.Proceedings of the National Academy of Sciences, 1996
- IgM and IgG but not cytokine secretion is restricted to the CD27+ B lymphocyte subsetThe Journal of Immunology, 1992